5'-(E)-VP-2'-OMe-U Phosphoramidite
Oligonucleotide Synthesis, RNA Raw Materials & Modification
Resumen del producto
Vista rápida
- Familia de productos
- Oligonucleotide Synthesis, RNA Raw Materials & Modification
- FM
- C32H52N4O13P2
- PM
- 762.7
- Pureza
- 99% (HPLC)
5'-(E)-VP-2'-OMe-U Phosphoramidite is a 5'-terminal building block for a 5'-(E)-vinylphosphonate phosphate-mimic motif: a 2'-O-methyluridine carrying a protected 5'-(E)-vinylphosphonate group at the 5'-position and a 3'-O-(2-cyanoethyl N,N-diisopropyl)phosphoramidite. Its PubChem-backed identity includes CAS 2172373-55-4, molecular formula C32H52N4O13P2, molecular weight 762.7, and PubChem CID 172639621.
Cited literature describes 5'-(E)-vinylphosphonate (5'-VP) as a metabolically stable mimic of the natural 5'-monophosphate, where the bridging 5'-oxygen is replaced by a vinyl carbon. Because the 5'-position carries the vinylphosphonate in place of the usual 5'-DMT, this monomer is the 5'-terminal residue, added last. Uracil has no exocyclic amine, so no base protecting group is needed. Cited 2'-OMe literature provides RNA-binding and nuclease-stability context for the 2'-O-methyl group, and the protected vinylphosphonate amidite format is cited for solid-phase synthesis.
Sinónimos
5'-(E)-vinylphosphonate-2'-OMe-U 3'-CE phosphoramidite; 5'-VP-2'-OMe-rU amidite (5'-terminal)
Identidad y especificaciones
| Catalog No. | CH65121 |
| CAS No. | 2172373-55-4 |
| Molecular Formula | C32H52N4O13P2 |
| Molecular Weight | 762.7 |
| PubChem CID | 172639621 |
| InChIKey | AJJPYIXDIHURAB-FQIYNDLNSA-N |
| Purity | 99% (HPLC) |
Condiciones de almacenamiento
-20 C
Atributos técnicos
- Monomer class
- 5'-(E)-vinylphosphonate phosphoramidite
- Nucleobase
- Uracil
- Sugar modification
- 2'-O-methyl
- Terminal motif
- 5'-(E)-vinylphosphonate
- Packaging
- 10 mg; 100 mg; 250 mg; 500 mg; 1 g; 5 g; 10 g; 25 g; 50 g; 100 g; 500 g; 1 kg; 2 kg; 5 kg; 25 kg; Custom packaging on request
- Solution concentration
- 10 mM in DMSO; 1 mL presentation
- Water content
- <=0.5%
- Physical form
- white to off-white powder
- Stability
- >=4 years
Contexto de aplicación
- 5'-phosphate mimic context: provides a 5'-(E)-vinylphosphonate at the 5'-terminus, described in cited literature as a metabolically stable 5'-phosphate mimic.
- 5'-terminal residue: the vinylphosphonate occupies the 5'-position (in place of 5'-DMT), so this monomer is added last in the synthesis.
- 2'-OMe modification: cited 2'-OMe literature provides RNA-binding and nuclease-stability context; uracil needs no base protection.
Recursos técnicos relacionados
Fuentes públicas
- Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing
Journal of Organic Chemistry, 2021
Product-family technical context
- Solid-phase supports for oligonucleotide synthesis
Current Protocols in Nucleic Acid Chemistry, 2013
Product-family technical context
- Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis
Tetrahedron Letters, 1981
Product-family technical context
- Synthesis of deoxyoligonucleotides on a polymer support
Journal of the American Chemical Society, 1981
Product-family technical context
- Compuesto de PubChem 172639621
PubChem · CID 172639621
Preguntas frecuentes
Why is this monomer a 5'-terminal residue, and why does it need no base protection?
The vinylphosphonate occupies the 5'-position (in place of the usual 5'-DMT), so it is added last, at the 5'-end. Uracil has no reactive exocyclic amine, so no base protecting group is required.
Productos similares
¿Necesita ayuda para seleccionar materiales?
CHEMOS puede revisar adecuación del producto, estructura objetivo, preguntas de ruta, expectativas analíticas y necesidades de suministro del proyecto.